As it gears up for human clinical trials, biotech firm KeraNetics has quadrupled its space within Wake Forest Innovation Quarter as it heads — hopefully — toward FDA approval for its products.
At the helm of the firm, which is developing a keratin-based platform used to help tissue repair and heal itself, is Kim Westmoreland, a self-described serial entrepreneur who earlier in his career guided health care and technology companies to great success. He sees that same potential in KeraNetics, which seeks to help soldiers and civilians alike heal more quickly and effectively from thermal and radiation burns. . . . read article